FDA Investigator Lynette P Salisbury

Lynette P Salisbury has inspections in 2 countries as of 15 Sep 2023. Lynette P Salisbury has collaborated with a combinined 2458 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
69
Last Inspection Date:
15 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100000575
Country:
United States of America
Co-Investigator(s):
Alicia M Mozzachio, Ana P Barido, Anthony J Grace, Barbara A Burke, Barbara A Crowl, Barbara A Gullick, Barbara J Holladay, Barbara Janine Breithaupt, Brandon L Mariner, Brooke K Higgins, Brooke K Seeman, Byungja E Marciante, Candice C Mandera, Candice J Cortes, Carla C Tuite, Carol Mrivera Lopez, PhD, Catherine Whiteside, PhD, Chaltu N Wakijra, Charles Kerns, Charles M Kerns, BLT DO, Charles R Bonapace, PhD, Christian D Lynch (CDL), Christine M Smith, Christine M Whitby, CSO, Christine Mwhitby Smith, Chryste D Best, Cynthia A Harris, MD, RN, Cynthia Jim, CSO, Daniel R Azar, Daniel T Lee, David K Glasgow, David L Chon, Debra Bower, Diane T Bargo, Diane T O'brien, Donald L Lech, Douglas A Campbell, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Ellen A Humphrey, Emest F Bizjak, Erin L Mcfiren, Gale L Glinecki, George Pyramides, Gerald B Seaborn, Jr, Gerald W Miller, Hector J Colon Torres, Jackie A O'shaughnessy, PhD, Jacqueline A O'shaughnessy, PhD, Jacqueline A O'shaugnessy, PhD, Jacqueline Mdiaz Albertini, James M Simpson, Jean Blackston Hill, Jeanne D Shaffer, John Dan, John J Walsh, John J Welsh, PhD, John Kadavil, PhD, Jose R Hernandez, Joseph W Matthews, Julie D Bringger, Jyoti B Patel, PhD, Ke Zhang, Kenneth M Gordon, Kenneth Nieves, Kurt A Brorson, PhD, Laine P Myers, Lakisha M Williams, Linda D Godfrey, Linda S Mattingly, Lori A Holmquist, Lori A Holquist, Lori S Lawless, LT Luis O Rodriguez, LT Melanie M Mayor, USPHS, Lucilla Facchin, Martin K Yau, PhD, Matthew M Henciak, Melissa J Garcia, Merideth K Rose, Michael F Skelly, PhD, Natasha A Dezinna, Natasha A Harry, Nebil A Oumer, Nichole J Chamberlain, Nilufer M Tampal, PhD, Norman K Starks, Olaide Akinmade, Patricia A Morrow, Patrick C Klotzbuecher, Philip J Snoy, Rachel C Harrington, Rebecca Rodriguez, Richard Heath Coats, Robert L Hummel, Robin R Waller, Rose M Ashley, Sena G Dissmeyer, Sherry L Secrist, BLT DO, Soram Subramaniam, PhD, Stacey A Priest, State Agency, Stephanie I Shapley, Stephanie L Shapley, Stephanie Mangigian, MS/OSH, RN, Steven J Thurber, Steven P Donald, Susan M Jackson, Suzanne M Healy, Suzanne M Muchene, Tajah L Blackburn, Tamal K Chakraborti, PhD, Tamika E Allen, RN, Tanika E Allen, RN, Tiffani D Wilson, Toyin B Oladimeji, Tracy L Taras, Vesna V Stanoyevitch, Walter L Fava, Wanda Y Fields, Wanda Y Honeyblue, William H Linkroum, William L Bargo, Yvonne C Mcknight, Zhongren Wu

Lynette P Salisbury's Documents

Publish Date Document Type Title
November, 2000 FDA 483 Response Covance Laboratories, Inc. - Form 483R, 2000-11-28
October, 2002 FDA 483 Response Bioanalytical Systems Inc - Form 483R, 2002-11-08
October, 2005 FDA 483 Bioreliance Corporation - Form 483, 2005-10-20
November, 2000 FDA 483 Covance Laboratories, Inc. - Form 483, 2000-11-02
September, 2000 EIR Actavis Mid-Atlantic, LLC. - EIR, 2000-09-29
October, 2002 EIR Bioanalytical Systems Inc - EIR, 2002-10-30
February, 2002 FDA 483 National Irb Pharmakinetics Ct - Form 483, 2002-02-11
February, 2001 FDA 483 Atlantic Asthma & Allergy Center - Form 483, 2001-02-08
April, 2003 FDA 483 Response EMINENT Services Corporation - Form 483R, 2003-05-08
February, 2001 FDA 483 Response Matz, Jonathan MD - Form 483R, 2001-02-12
February, 2000 FDA 483 Thomas & Thompson Company, Inc. - Form 483, 2000-02-08
October, 2001 EIR Celsis In Vitro Inc. - EIR, 2001-10-12
July, 2000 EIR Advarra IRB - EIR, 2000-07-28
April, 2003 EIR EMINENT Services Corporation - EIR, 2003-04-02
June, 2001 FDA 483 Sitek Research Laboratories - Form 483, 2001-06-07
June, 2001 EIR Sitek Research Laboratories - EIR, 2001-06-07
November, 2005 EIR PAREXEL INTERNATIONAL CORPORATION - EIR, 2005-11-22
November, 2005 FDA 483 PAREXEL INTERNATIONAL CORPORATION - Form 483, 2005-11-22
November, 2005 FDA 483 Response PAREXEL INTERNATIONAL CORPORATION - Form 483R, 2005-11-30
January, 2004 FDA 483 Response Ritchie C. Shoemaker MD - Form 483R, 2004-01-16
August, 2002 EIR Option Care Pharmacy - EIR, 2002-08-08
April, 2003 FDA 483 EMINENT Services Corporation - Form 483, 2003-04-02
December, 2000 EIR Bioanalytical Systems Inc - EIR, 2000-12-19
October, 2001 FDA 483 Celsis In Vitro Inc. - Form 483, 2001-10-12
December, 2001 EIR Dovetail Technologies Inc - EIR, 2001-12-05
April, 2001 FDA 483 Bluemke, David A. MD - Form 483, 2001-04-30
April, 2001 EIR Bluemke, David A. MD - EIR, 2001-04-30
August, 2002 EIR Charles River Laboratories Inc - EIR, 2002-08-05
September, 2004 EIR Bioreliance Corporation - EIR, 2004-09-23
August, 2003 FDA 483 Sheri L. Rowen MD - Form 483, 2003-08-08
October, 2005 EIR Bioreliance Corporation - EIR, 2005-10-20
October, 2002 FDA 483 Bioanalytical Systems Inc - Form 483, 2002-10-30
January, 2004 FDA 483 Ritchie C. Shoemaker MD - Form 483, 2004-01-15
August, 2002 FDA 483 Option Care Pharmacy - Form 483, 2002-08-08
February, 2001 EIR Matz, Jonathan MD - EIR, 2001-02-08

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more